Loading…
Loading…
Trex (TREX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Data center and power demand, along with mission-critical projects, give these construction stocks, like INOD, AGX, TREX, PWR and STRL, strong growth momentum.
Trex (NYSE: TREX - Get Free Report) and Trane Technologies (NYSE: TT - Get Free Report) are both industrials companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Insider and Institutional Ownership 96.0% of Trex shares are
WINCHESTER, Va.--(BUSINESS WIRE)-- #Trex30--The executive leadership of Trex Company [NYSE: TREX], the world's largest manufacturer of wood-alternative decking and railing, and a leading brand of high-performance, low-maintenance outdoor living products, will ring The Opening Bell® at the New York Stock Exchange (NYSE) today to commemorate the 30th anniversary of the company's founding. The celebration recognizes three decades of innovation and growth that started with one category-defining invention and.
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Oct. 20, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
DECK, TREX and BC offer double-digit short-term upside potential, backed by growth prospects, stronger earnings estimates and favorable price targets.
WINCHESTER, Va.--(BUSINESS WIRE)--Trex Company, Inc. [NYSE: TREX], the world's largest manufacturer of wood-alternative composite decking and railing, and a leader in high-performance, low-maintenance outdoor living products, will issue its third quarter 2026 earnings release on Wednesday, November 4, 2026, at 6:30 AM ET. You are invited to participate in the Company's conference call hosted by senior management on Wednesday, November 4, 2026, at 8:00 AM ET. Their prepared remarks will be follo.
Drug developers Retension Pharmaceuticals and TRex Bio filed their paperwork for U.S. initial public offerings on Friday, reinforcing the biotech pipeline for the fall IPO window.